XOMA

$39.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.65 (+1.68%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell XOMA and other stocks, options, and ETFs commission-free!

About XOMA

XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA. The listed name for XOMA is XOMA Corporation Common Stock.

CEO

James R. Neal

Employees

Headquarters

Emeryville, California

Founded

1981

Market Cap

433.06M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

25.32K

High Today

$39.50

Low Today

$35.46

Open Price

$38.23

Volume

34.57K

52 Week High

$46.32

52 Week Low

$14.14

Collections

XOMA Earnings

-$0.55

-$0.30

-$0.05

$0.20

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 9, Pre-Market